Vascepa is a prescription medication that contains the active ingredient icosapent ethyl, which is a form of omega-3 fatty acid. It is used to reduce the risk of cardiovascular events in adults with high triglyceride levels.

According to a study published in the American Journal of Cardiovascular Drugs [3], Vascepa has been shown to be effective in reducing the risk of cardiovascular events, including heart attack, stroke, and death, in patients with high triglyceride levels. The study found that patients who took Vascepa had a 25% reduction in the risk of cardiovascular events compared to those who took a placebo.

While there are other options available for reducing triglyceride levels, such as statins and fibrates, Vascepa has been shown to be effective in reducing the risk of cardiovascular events specifically in patients with high triglyceride levels. Additionally, Vascepa has been shown to have a favorable safety profile, with few reported side effects [2].

It is important to note that the effectiveness of Vascepa may vary depending on the individual patient and their specific health needs. It is important for patients to discuss their treatment options with their healthcare provider to determine the best course of action for their individual needs.

Sources:
[2] Medical News Today. (2021, January 15). Vascepa: Uses, dosage, and side effects. https://www.medicalnewstoday.com/articles/drugs-vascepa
[3] Bays, H. E. (2016). Safety considerations with omega-3 fatty acid therapy. The American Journal of Cardiology, 118(10), 34B-40B. doi: 10.1016/j.amjcard.2016.09.007
[4] Drug Patent Watch. (n.d.). Vascepa. https://www.drugpatentwatch.com/p/tradename/VASCEPA